Enzyme replacement therapy in late-onset type II glycogenosis.
Merk
T
T
D006009:Glycogen Storage Disease Type II / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D014797:Vital Capacity / Q000187:drug effects / Q000502:physiology; D000520:alpha-Glucosidases / Q000627:therapeutic use*
D000520:alpha-Glucosidases